Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hoos

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Pigment Cell & Melanoma Research|May 22, 2015
Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumabDavid R Minor, Igor Puzanov, Margaret K Callahan, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2006
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancerTomislav Dragovich, David Mendelson, Sandra Kurtin, et al.
Vaccine|November 2, 2007
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC)Lothar H Finke, Kerry Wentworth, Brent Blumenstein, et al.
Medical Oncology (Northwood, London, England)|July 2, 2010
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapyKaan Harmankaya, Christa Erasim, Claus Koelblinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Case Report: response to ipilimumab in a patient with HIV with metastatic melanomaMatthew M Burke, Harriet M Kluger, Marjorie Golden, et al.
Cancer Immunity|July 25, 2013
Structured reporting of T cell assay resultsSylvia Janetzki, Axel Hoos, Cornelis J M Melief, et al.
Nature Protocols|June 26, 2015
Guidelines for the automated evaluation of Elispot assaysSylvia Janetzki, Leah Price, Helene Schroeder, et al.
Journal of the American College of Surgeons|June 6, 2003
An evidence-based approach to the surgical management of resectable pancreatic adenocarcinomaAlexander Stojadinovic, Ari Brooks, Axel Hoos, et al.
Melanoma Research|March 11, 2010
Complete regression of a previously untreated melanoma brain metastasis with ipilimumabNoël E C Schartz, Cécile Farges, Isabelle Madelaine, et al.
Annals of Surgery|March 8, 2002
Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomasAlexander Stojadinovic, Denis H Y Leung, Axel Hoos, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Pigment Cell & Melanoma Research|May 22, 2015
Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumabDavid R Minor, Igor Puzanov, Margaret K Callahan, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2006
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancerTomislav Dragovich, David Mendelson, Sandra Kurtin, et al.
Vaccine|November 2, 2007
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC)Lothar H Finke, Kerry Wentworth, Brent Blumenstein, et al.
Medical Oncology (Northwood, London, England)|July 2, 2010
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapyKaan Harmankaya, Christa Erasim, Claus Koelblinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Case Report: response to ipilimumab in a patient with HIV with metastatic melanomaMatthew M Burke, Harriet M Kluger, Marjorie Golden, et al.
Cancer Immunity|July 25, 2013
Structured reporting of T cell assay resultsSylvia Janetzki, Axel Hoos, Cornelis J M Melief, et al.
Nature Protocols|June 26, 2015
Guidelines for the automated evaluation of Elispot assaysSylvia Janetzki, Leah Price, Helene Schroeder, et al.
Journal of the American College of Surgeons|June 6, 2003
An evidence-based approach to the surgical management of resectable pancreatic adenocarcinomaAlexander Stojadinovic, Ari Brooks, Axel Hoos, et al.
Melanoma Research|March 11, 2010
Complete regression of a previously untreated melanoma brain metastasis with ipilimumabNoël E C Schartz, Cécile Farges, Isabelle Madelaine, et al.
Annals of Surgery|March 8, 2002
Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomasAlexander Stojadinovic, Denis H Y Leung, Axel Hoos, et al.
Pageof 8